153 related articles for article (PubMed ID: 15514209)
21. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
Pampuch A; Cerletti C; de Gaetano G
Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
[TBL] [Abstract][Full Text] [Related]
22. Shear-induced global thrombosis test of native blood: pivotal role of ADP allows monitoring of P2Y12 antagonist therapy.
Saraf S; Wellsted D; Sharma S; Gorog DA
Thromb Res; 2009 Sep; 124(4):447-51. PubMed ID: 19476973
[TBL] [Abstract][Full Text] [Related]
23. The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation.
Léon C; Vial C; Gachet C; Ohlmann P; Hechler B; Cazenave JP; Lecchi A; Cattaneo M
Thromb Haemost; 1999 May; 81(5):775-81. PubMed ID: 10365753
[TBL] [Abstract][Full Text] [Related]
24. Molecular modeling of purinergic receptor P2Y12 and interaction with its antagonists.
Zhan C; Yang J; Dong XC; Wang YL
J Mol Graph Model; 2007 Jul; 26(1):20-31. PubMed ID: 17110146
[TBL] [Abstract][Full Text] [Related]
25. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
Gachet C
Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties?
Baurand A; Eckly A; Hechler B; Kauffenstein G; Galzi JL; Cazenave JP; Léon C; Gachet C
Mol Pharmacol; 2005 Mar; 67(3):721-33. PubMed ID: 15602005
[TBL] [Abstract][Full Text] [Related]
27. PI3-kinase is essential for ADP-stimulated integrin alpha(IIb)beta3-mediated platelet calcium oscillation, implications for P2Y receptor pathways in integrin alpha(IIb)beta3-initiated signaling cross-talks.
Sun DS; Lo SJ; Tsai WJ; Lin CH; Yu MS; Chen YF; Chang HH
J Biomed Sci; 2005 Dec; 12(6):937-48. PubMed ID: 16228296
[TBL] [Abstract][Full Text] [Related]
28. Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy.
Smith SM; Judge HM; Peters G; Armstrong M; Fontana P; Gaussem P; Daly ME; Storey RF
Platelets; 2006 Jun; 17(4):250-8. PubMed ID: 16769602
[TBL] [Abstract][Full Text] [Related]
29. ADP receptors of platelets and their inhibition.
Gachet C
Thromb Haemost; 2001 Jul; 86(1):222-32. PubMed ID: 11487010
[TBL] [Abstract][Full Text] [Related]
30. The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation.
Nylander S; Mattsson C; Ramström S; Lindahl TL
Thromb Res; 2003; 111(1-2):65-73. PubMed ID: 14644082
[TBL] [Abstract][Full Text] [Related]
31. Calmodulin interacts with the platelet ADP receptor P2Y1.
Arthur JF; Shen Y; Mu FT; Leon C; Gachet C; Berndt MC; Andrews RK
Biochem J; 2006 Sep; 398(3):339-43. PubMed ID: 16848759
[TBL] [Abstract][Full Text] [Related]
32. Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function.
Mundell SJ; Jones ML; Hardy AR; Barton JF; Beaucourt SM; Conley PB; Poole AW
Mol Pharmacol; 2006 Sep; 70(3):1132-42. PubMed ID: 16804093
[TBL] [Abstract][Full Text] [Related]
33. Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity.
Leon C; Ravanat C; Freund M; Cazenave JP; Gachet C
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1941-7. PubMed ID: 12933533
[TBL] [Abstract][Full Text] [Related]
34. ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways.
Shen J; DiCorleto PE
Circ Res; 2008 Feb; 102(4):448-56. PubMed ID: 18174464
[TBL] [Abstract][Full Text] [Related]
35. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
[TBL] [Abstract][Full Text] [Related]
36. P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study.
Fontana P; Gaussem P; Aiach M; Fiessinger JN; Emmerich J; Reny JL
Circulation; 2003 Dec; 108(24):2971-3. PubMed ID: 14662702
[TBL] [Abstract][Full Text] [Related]
37. Association between P2Y1 and P2Y12 polymorphisms and acute myocardial infarction and ADP-induced platelet aggregation.
Su C; Zhang Z; Chen J; Tian M; Wu C; Zhang T
BMC Cardiovasc Disord; 2023 Jan; 23(1):41. PubMed ID: 36681816
[TBL] [Abstract][Full Text] [Related]
38. Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel.
Malinin A; Pokov A; Swaim L; Kotob M; Serebruany V
Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):315-22. PubMed ID: 16845449
[TBL] [Abstract][Full Text] [Related]
39. Platelet collagen receptor integrin alpha2beta1 activation involves differential participation of ADP-receptor subtypes P2Y1 and P2Y12 but not intracellular calcium change.
Jung SM; Moroi M
Eur J Biochem; 2001 Jun; 268(12):3513-22. PubMed ID: 11422381
[TBL] [Abstract][Full Text] [Related]
40. Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome.
Frere C; Cuisset T; Morange PE; Quilici J; Camoin-Jau L; Saut N; Faille D; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
Am J Cardiol; 2008 Apr; 101(8):1088-93. PubMed ID: 18394438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
